A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).

NCT01305252 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Hypertension, Pulmonary

Interventions

DRUG: treprostinil inhalations
DRUG: tadalafil

Sponsor

Stanford University

Collaborators

[object Object]